Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression
Jie Wang, Yunshan Wang, Ya‐Ping Huang, Cuihua Jiang, Meng Gao, Xian Zheng, Zhi‐Qi Yin, Jian Zhang
Topics & Concepts
PCSK9LDL receptorGynostemma pentaphyllumHyperlipidemiaKexinChemistryLipoproteinAtorvastatinFlow cytometryLow-density lipoproteinCholesterolPharmacologyBiochemistryMedicineEndocrinologyBiologyMolecular biologyChromatographyExtraction (chemistry)Diabetes mellitusLipoproteins and Cardiovascular HealthLipid metabolism and disordersCancer, Lipids, and Metabolism